Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trophinin-associated protein (TROAP, also known as tastin) is a cytoplasmic protein that plays critical roles in cell adhesion (especially during embryo implantation), microtubule cytoskeleton assembly, and mitotic spindle formation. TROAP is essential for the activity of the trophinin-bystin complex in mediating initial attachment between embryonic cells and the uterine epithelium. Beyond its established developmental roles, TROAP is frequently overexpressed in a variety of human cancers—where it acts as a key factor in promoting tumor cell proliferation, cell cycle progression, migration, and invasion, likely through interaction with multiple oncogenic signaling pathways. In multiple tumor types, high TROAP expression correlates with poor prognosis, tumor aggressiveness, and reduced overall survival, positioning it as a potential prognostic biomarker and therapeutic target in oncology[1][3][4][6].
null (no approved mechanism of action for any drug directly targeting TROAP; overexpression promotes oncogenic signaling and spindle assembly, but not a direct pharmacological mechanism)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trophinin-associated protein (TROAP).